Qiagen NV
NYSE:QGEN 4:00:00 PM EDT
| Market Cap (Intraday) | 10.51B |
| Current PE | 112.24 |
| Forward PE | 20.66 |
| 2yr Forward PE | 19.19 |
| 10-Day MA | $47.94 |
| 50-Day MA | $45.08 |
| 200-Day MA | $43.79 |
Qiagen NV Stock, NYSE:QGEN
Hulsterweg 82, Venlo, Limburg 5912 PL
Netherlands
Phone: +31.77.355.66.00
Number of Employees: 5967
Description
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.